| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.09 |